Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Free Cash Flow Generation Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Free Cash Flow Generation Index of 0.76x as of March 2023. Free cash flow of €142.49 Million represents 1% of operating cash flow (€186.97 Million). Explore capital reinvestment ratio of Tianjin Zhong Xin Pharmaceutical Group C to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 12 annual periods. For the full cash flow conversion analysis, see Tianjin Zhong Xin Pharmaceutical Group C cash conversion from operations.
Annual Free Cash Flow Generation for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. Check cash flow reinvestment rate of Tianjin Zhong Xin Pharmaceutical Group C to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €342.45 Million | €461.07 Million | €118.61 Million | ▼ -14.9% |
| 2024 | 0.87x | €806.86 Million | €924.67 Million | €117.81 Million | ▲ +9.7% |
| 2023 | 0.80x | €547.56 Million | €688.49 Million | €140.93 Million | ▼ -5.4% |
| 2022 | 0.84x | €569.34 Million | €677.25 Million | €107.90 Million | ▲ +3.0% |
| 2021 | 0.82x | €695.45 Million | €852.40 Million | €156.95 Million | ▲ +13.6% |
| 2020 | 0.72x | €482.26 Million | €671.42 Million | €189.16 Million | ▲ +22.8% |
| 2019 | 0.59x | €289.87 Million | €495.49 Million | €205.61 Million | ▲ +17.5% |
| 2018 | 0.50x | €174.34 Million | €350.14 Million | €175.81 Million | ▼ -61.0% |
| 2016 | 1.28x | €533.98 Million | €417.77 Million | €116.20 Million | ▲ +1.7% |
| 2015 | 1.26x | €453.22 Million | €360.58 Million | €92.64 Million | ▲ +1.0% |
| 2014 | 1.24x | €357.01 Million | €286.85 Million | €70.15 Million | ▼ -7.1% |
| 2013 | 1.34x | €285.86 Million | €213.44 Million | €72.42 Million | — |